Notification on controlled drugs

Providers should notify the Care Inspectorate to any adverse events and concerns involving schedule 2, 3, 4, and 5 controlled drugs used in care settings, when they occur, and while the service user is receiving care in the care service.

Please note, it is a legal requirement for care services to notify the Care Inspectorate of the matters listed in this document. Where the requirement is limited to a specific type of care service, this is detailed in the guidance.

Care services and local authorities must use our eForms system to make these notifications.